Cargando…
Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy
OBJECTIVE: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP). SETTINGS: Retrospective case-control study. METHOD: Univ...
Autores principales: | Cheng, Feng, Shan, Dan, Guo, Sijia, Cheng, Shuang, Yang, Hongwei, Han, Jialin, Hu, Tongxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040523/ https://www.ncbi.nlm.nih.gov/pubmed/31195943 http://dx.doi.org/10.2174/1566524019666190612135728 |
Ejemplares similares
-
Curettage after uterine artery embolization combined with methotrexate treatment for caesarean scar pregnancy
por: Feng, Ying, et al.
Publicado: (2016) -
Assessment of the necessity of uterine artery embolization during suction and curettage for caesarean scar pregnancy: a prospective cohort study
por: Ou, Jie, et al.
Publicado: (2020) -
Management of persistent caesarean scar pregnancy after curettage treatment failure
por: Qian, Zhi-Da, et al.
Publicado: (2017) -
Analysis on clinical effects of dilation and curettage guided by ultrasonography versus hysteroscopy after uterine artery embolization in the treatment of cesarean scar pregnancy
por: Qiu, Jian, et al.
Publicado: (2019) -
Role of collateral embolization in addition to uterine artery embolization followed by hysteroscopic curettage for the management of cesarean scar pregnancy
por: Zhang, Guodong, et al.
Publicado: (2019)